作为药物中间体（具体用途未明确说明，基于其在医药相关专利中的应用）
医药
合成路线 1（1. 合成：464913-11-9）
产率：100%
合成条件：With palladium 10% on activated carbon; hydrogen In ethanol
实验步骤：步骤7 3-氨基-2-羟基-N，N-二甲基苯甲酰胺将33.5g 2-羟基-N，N-二甲基-3-硝基苯甲酰胺在600ml乙醇中的溶液加入到3.35g Pd /的悬浮液中 C在10ml的70ml乙醇中。 将反应介质在2巴氢气下搅拌过夜。 TLC和HPLC对照（t = 0.66 M + 181）。 将反应介质通过硅藻土过滤，蒸发滤液。 获得29g油状棕色固体形式的3-氨基-2-羟基-N，N-二甲基苯甲酰胺。产率=100PERCENT。
参考文献：
- [1] Patent: US2014/296254, 2014, A1. Location in patent: Paragraph 0102 [2] Patent: US2014/309208, 2014, A1. Location in patent: Paragraph 0110; 0115 [3] Patent: US2015/87675, 2015, A1. Location in patent: Paragraph 0152 [4] Patent: WO2004/33440, 2004, A1. Location in patent: Page 166 [5] Patent: US2004/147559, 2004, A1. Location in patent: Page 80 [6] Patent: US2004/106794, 2004, A1. Location in patent: Page 83 [7] Patent: WO2005/66147, 2005, A1. Location in patent: Page/Page column 138 [8] Patent: WO2005/68460, 2005, A1. Location in patent: Page/Page column 141 [9] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3778 - 3783 [10] Patent: WO2010/91543, 2010, A1. Location in patent: Page/Page column 23-24 [11] Patent: WO2008/5570, 2008, A1. Location in patent: Page/Page column 70-71 [12] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 15, p. 4107 - 4110 [13] Journal of Medicinal Chemistry, 2006, vol. 49, # 26, p. 7603 - 7606 [14] Patent: WO2005/66147, 2005, A1. Location in patent: Page/Page column 124-125 [15] Patent: WO2010/63802, 2010, A1. Location in patent: Page/Page column 42 [16] RSC Advances, 2018, vol. 8, # 20, p. 11061 - 11069 [17] Patent: WO2008/148790, 2008, A1. Location in patent: Page/Page column 26-27
